Orthocell Limited (ASX:OCC – Get Free Report) insider John Wielen bought 35,000 shares of the business’s stock in a transaction dated Monday, April 15th. The shares were bought at an average cost of A$0.39 ($0.25) per share, with a total value of A$13,650.00 ($8,806.45).
Orthocell Price Performance
The company has a quick ratio of 5.07, a current ratio of 4.60 and a debt-to-equity ratio of 34.88.
Orthocell Company Profile
Further Reading
- Five stocks we like better than Orthocell
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Comprehensive PepsiCo Stock Analysis
- What is the Euro STOXX 50 Index?
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Orthocell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthocell and related companies with MarketBeat.com's FREE daily email newsletter.